WO1998035985B1 - Protein markers for lung cancer and use thereof - Google Patents
Protein markers for lung cancer and use thereofInfo
- Publication number
- WO1998035985B1 WO1998035985B1 PCT/IB1998/000361 IB9800361W WO9835985B1 WO 1998035985 B1 WO1998035985 B1 WO 1998035985B1 IB 9800361 W IB9800361 W IB 9800361W WO 9835985 B1 WO9835985 B1 WO 9835985B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- animal
- human
- spot
- lung cancer
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract 10
- 108090000623 proteins and genes Proteins 0.000 title claims abstract 10
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims 3
- 201000005202 lung cancer Diseases 0.000 title claims 3
- 206010028980 Neoplasm Diseases 0.000 claims abstract 8
- 210000004072 Lung Anatomy 0.000 claims abstract 5
- 210000002966 Serum Anatomy 0.000 claims 2
- 230000002018 overexpression Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
Abstract
Computerized analysis of 2-D gels, both carrier ampholyte (CA) and immobilized pH gradient (IPG) based, of the proteins in tissue from lung tumors, reveals proteins which are different types of tumors and in control tissues.
Claims
AMENDED CLAIMS
[received by the International Bureau on 25 September 1998 (25.09.98); new claims 19-24 added, remaining claims unchanged (1 page)]
18. A method of treating a tumor in an animal or human in need thereof
comprising: a) exposing immunocompetent cells from the animal or human to at least
one protein selected from the group consisting of Spot 14, 15, 16, 17, 21 , 22, 27,
29, 31 , 33, 40, 42, 43, 47, 50, 53, 57, 58, 59, 61 , 62, 66, 67, 68, 73, 74, 79, 80,
81 , 83, 84, 86, 90, 92, 94, 95, 96, 97, 98, 100, 101 , 102, 105, 106, 107, and 109;
and b) injecting said immunocompetent cells into the animal or human to treat
a tumor.
19. A method for diagnosing lung cancer in an animal or human,
comprising detecting at least one protein which is overexpressed in lung tumors
in a sample from the animal or human, and correlating the detection of the
protein with the presence of lung tumor.
20. The method of claim 19, wherein the sample is serum.
21. The method of claim 19, wherein the at least one protein is spot 107
or spot 109.
22. A method for diagnosing lung cancer in an animal or human,
comprising detecting the overexpression of at least one protein which is
overexpressed in lung tumors in a sample from the animal or human, and
correlating the overexpression of the protein with the presence of lung tumor.
23. The method of claim 22, wherein the sample is serum.
24. The method of claim 22, wherein the at least one protein is spot 107
or spot 109.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53551498A JP4367866B2 (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and uses thereof |
| NZ337750A NZ337750A (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and use thereof |
| DE69837529T DE69837529T2 (en) | 1997-02-12 | 1998-02-12 | PROTEIN MARKERS FOR LUNG CANCER AND ITS USE |
| EP98905576A EP0961780B1 (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and use thereof |
| AU61112/98A AU6111298A (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and use thereof |
| CA2280930A CA2280930C (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and use thereof |
| DK98905576T DK0961780T3 (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and its use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3881997P | 1997-02-12 | 1997-02-12 | |
| US60/038,819 | 1997-02-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1998035985A1 WO1998035985A1 (en) | 1998-08-20 |
| WO1998035985B1 true WO1998035985B1 (en) | 1998-11-12 |
Family
ID=21902087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB1998/000361 WO1998035985A1 (en) | 1997-02-12 | 1998-02-12 | Protein markers for lung cancer and use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20020192228A1 (en) |
| EP (1) | EP0961780B1 (en) |
| JP (1) | JP4367866B2 (en) |
| AT (1) | ATE359515T1 (en) |
| AU (1) | AU6111298A (en) |
| CA (1) | CA2280930C (en) |
| DE (1) | DE69837529T2 (en) |
| DK (1) | DK0961780T3 (en) |
| ES (1) | ES2284200T3 (en) |
| NZ (1) | NZ337750A (en) |
| WO (1) | WO1998035985A1 (en) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696247B2 (en) | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6660838B1 (en) | 1998-03-18 | 2003-12-09 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6482597B1 (en) | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6518256B1 (en) | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6737514B1 (en) | 1998-12-22 | 2004-05-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| US6821518B1 (en) | 1998-03-18 | 2004-11-23 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6531315B1 (en) | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
| US6426072B1 (en) | 2000-08-02 | 2002-07-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6312695B1 (en) | 1998-03-18 | 2001-11-06 | Corixa Corporation | Compounds and methods for therapy of lung cancer |
| AU2004201392B2 (en) * | 1998-11-05 | 2007-06-14 | The Regents Of The University Of Michigan | S100 proteins and autoantibodies as serum markers for cancer |
| ATE447713T1 (en) * | 1998-11-05 | 2009-11-15 | Univ Michigan | S100 PROTEINS AND AUTOANTIBODIES AS SERUM MARKERS FOR CANCER |
| ES2308976T3 (en) * | 1999-04-02 | 2008-12-16 | Corixa Corporation | COMPOUNDS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CANCER DE PULMON. |
| JP4287147B2 (en) | 2000-11-02 | 2009-07-01 | イミュノセルラー・セラピューティクス・リミテッド | Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| US6939670B2 (en) * | 2001-03-12 | 2005-09-06 | Monogen, Inc. | Cell-based detection and differentiation of lung cancer |
| WO2004004770A1 (en) * | 2002-07-05 | 2004-01-15 | Universite Laval | Chemotactic factor inhibitor for modulating inflammatory reactions |
| AU2002951153A0 (en) * | 2002-09-02 | 2002-09-19 | Proteome Systems Intellectual Property Pty Ltd | An electrophoresis gel having improved swelling properties |
| JP5710854B2 (en) * | 2004-05-11 | 2015-04-30 | アブゲノミクス コーペラティフ ユー．エー． | T cell death-inducing epitope |
| US20070231317A1 (en) * | 2004-07-13 | 2007-10-04 | Universite Laval | S100 Protein Inhibitors for Treating Leukemia |
| US7659087B2 (en) * | 2004-07-23 | 2010-02-09 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| SG150497A1 (en) | 2004-07-23 | 2009-03-30 | Aspenbio Pharma Inc | Methods and devices for diagnosis of appendicitis |
| CN102304086B (en) | 2005-05-18 | 2013-12-04 | 阵列生物制药公司 | Heterocyclic inhibitors of MEK and methods of use thereof |
| KR100732298B1 (en) * | 2005-11-24 | 2007-06-25 | 이화여자대학교 산학협력단 | - -1 Composition for diagnosing cancer metastasis using ubiquitin C-terminal hydrolase-L1 |
| TW200813091A (en) | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
| CL2007002225A1 (en) | 2006-08-03 | 2008-04-18 | Astrazeneca Ab | SPECIFIC UNION AGENT FOR A RECEIVER OF THE GROWTH FACTOR DERIVED FROM PLATES (PDGFR-ALFA); NUCLEIC ACID MOLECULA THAT CODIFIES IT; VECTOR AND CELL GUESTS THAT UNDERSTAND IT; CONJUGADO UNDERSTANDING THE AGENT; AND USE OF THE AGENT OF A |
| PL2057156T3 (en) | 2006-08-23 | 2017-08-31 | Kudos Pharmaceuticals Limited | 2-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| JPWO2008114819A1 (en) | 2007-03-20 | 2010-07-08 | 大日本住友製薬株式会社 | New adenine compounds |
| TW200902018A (en) | 2007-03-20 | 2009-01-16 | Dainippon Sumitomo Pharma Co | Novel adenine compound |
| US20090069189A1 (en) * | 2007-09-11 | 2009-03-12 | Cancer Prevention And Cure, Ltd. | Method of identifying proteins in human serum indicative of pathologies of human lung tissues |
| KR101494734B1 (en) | 2007-10-11 | 2015-02-26 | 아스트라제네카 아베 | Pyrrolo[ 2,3-d] pyrimidin derivatives as protein kinase b inhibitors |
| DK2222675T3 (en) | 2007-12-19 | 2013-11-04 | Genentech Inc | 5-ANILINOIMIDAZOPYRIDINES AND PROCEDURES FOR THEIR USE |
| JP5710269B2 (en) | 2007-12-21 | 2015-04-30 | ジェネンテック， インコーポレイテッド | Azaindolizines and usage |
| JP5778577B2 (en) | 2008-09-19 | 2015-09-16 | メディミューン，エルエルシー | Antibodies against DLL4 and uses thereof |
| TW201028410A (en) | 2008-12-22 | 2010-08-01 | Astrazeneca Ab | Chemical compounds 610 |
| CA2748158A1 (en) | 2008-12-23 | 2010-07-01 | Astrazeneca Ab | Targeted binding agents directed to .alpha.5.beta.1 and uses thereof |
| NZ594177A (en) | 2009-02-05 | 2014-02-28 | Immunogen Inc | Novel benzodiazepine derivatives |
| ES2703714T3 (en) | 2009-03-12 | 2019-03-12 | Cancer Prevention & Cure Ltd | Methods of identification, evaluation, prevention and therapy of pulmonary diseases and kits thereof, including the identification, evaluation, prevention and therapy of diseases on the basis of gender |
| CA2755061A1 (en) | 2009-03-13 | 2010-09-16 | Cellzome Limited | Pyrimidine derivatives as mtor inhibitors |
| CA2758614A1 (en) | 2009-04-14 | 2010-10-21 | Cellzome Limited | Fluoro substituted pyrimidine compounds as jak3 inhibitors |
| US8389580B2 (en) | 2009-06-02 | 2013-03-05 | Duke University | Arylcyclopropylamines and methods of use |
| WO2011029807A1 (en) | 2009-09-11 | 2011-03-17 | Cellzome Limited | Ortho substituted pyrimidine compounds as jak inhibitors |
| TW201125867A (en) | 2009-10-20 | 2011-08-01 | Cellzome Ltd | Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors |
| CA2778714C (en) | 2009-11-24 | 2018-02-27 | Medimmune Limited | Targeted binding agents against b7-h1 |
| WO2011068233A1 (en) | 2009-12-03 | 2011-06-09 | Dainippon Sumitomo Pharma Co., Ltd. | Imidazoquinolines which act via toll - like receptors (tlr) |
| US20120315641A1 (en) * | 2010-01-08 | 2012-12-13 | The Regents Of The University Of California | Protein Markers for Lung Cancer Detection and Methods of Using Thereof |
| AU2011215900A1 (en) | 2010-02-10 | 2012-07-26 | Immunogen, Inc. | CD20 antibodies and uses thereof |
| ES2535116T3 (en) | 2010-03-04 | 2015-05-05 | Cellzome Limited | Urea derivatives with morpholino as mtor inhibitors |
| SG184989A1 (en) | 2010-04-30 | 2012-11-29 | Cellzome Ltd | Pyrazole compounds as jak inhibitors |
| SA111320519B1 (en) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | Pyrimidinyl Compounds for Use as ATR Inhibitors |
| EP2588105A1 (en) | 2010-07-01 | 2013-05-08 | Cellzome Limited | Triazolopyridines as tyk2 inhibitors |
| US9040545B2 (en) | 2010-08-20 | 2015-05-26 | Cellzome Limited | Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitors |
| EP2638018A1 (en) | 2010-11-09 | 2013-09-18 | Cellzome Limited | Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
| US9353127B2 (en) | 2011-02-15 | 2016-05-31 | Immunogen, Inc. | Methods of preparation of conjugates |
| WO2012110773A1 (en) | 2011-02-17 | 2012-08-23 | Cancer Therapeutics Crc Pty Limited | Fak inhibitors |
| JP5937112B2 (en) | 2011-02-17 | 2016-06-22 | カンサー・セラピューティクス・シーアールシー・プロプライエタリー・リミテッドＣａｎｃｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｒｃ Ｐｔｙ Ｌｉｍｉｔｅｄ | Selective FAK inhibitor |
| JP2014510122A (en) | 2011-04-04 | 2014-04-24 | セルゾーム リミテッド | Dihydropyrrolopyrimidine derivatives as mTOR inhibitors |
| WO2012143320A1 (en) | 2011-04-18 | 2012-10-26 | Cellzome Limited | (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors |
| KR20140047092A (en) | 2011-07-28 | 2014-04-21 | 셀좀 리미티드 | Heterocyclyl pyrimidine analogues as jak inhibitors |
| WO2013017479A1 (en) | 2011-07-29 | 2013-02-07 | Cellzome Limited | Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| WO2013017480A1 (en) | 2011-07-29 | 2013-02-07 | Cellzome Limited | Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| JP2014531449A (en) | 2011-09-20 | 2014-11-27 | セルゾーム リミティッド | Pyrazolo [4,3-c] pyridine derivatives as kinase inhibitors |
| US9175011B2 (en) | 2011-09-21 | 2015-11-03 | Cellzone Limited | Morpholino substituted urea or carbamate derivatives as MTOR inhibitors |
| KR20140084130A (en) | 2011-10-07 | 2014-07-04 | 셀좀 리미티드 | Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors |
| KR20140114344A (en) | 2011-12-23 | 2014-09-26 | 셀좀 리미티드 | Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
| US20130178520A1 (en) | 2011-12-23 | 2013-07-11 | Duke University | Methods of treatment using arylcyclopropylamine compounds |
| EP3505534A1 (en) | 2012-06-08 | 2019-07-03 | Sutro Biopharma, Inc. | Antibodies comprising sitespecific nonnatural amino acid residues, methods of their preparation and methods of their use |
| US9732161B2 (en) | 2012-06-26 | 2017-08-15 | Sutro Biopharma, Inc. | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use |
| WO2014026243A1 (en) | 2012-08-17 | 2014-02-20 | Cancer Therapeutics Crc Pty Limited | Vegfr3 inhibitors |
| WO2014031566A1 (en) | 2012-08-22 | 2014-02-27 | Immunogen, Inc. | Cytotoxic benzodiazepine derivatives |
| PL3584255T3 (en) | 2012-08-31 | 2022-05-16 | Sutro Biopharma, Inc. | Modified amino acids comprising an azido group |
| WO2014041349A1 (en) | 2012-09-12 | 2014-03-20 | Cancer Therapeutics Crc Pty Ltd | Tetrahydropyran-4-ylethylamino- or tetrahydropyranyl-4-ethyloxy-pyrimidines or -pyridazines as isoprenylcysteincarboxymethyl transferase inhibitors |
| WO2014045101A1 (en) | 2012-09-21 | 2014-03-27 | Cellzome Gmbh | Tetrazolo quinoxaline derivatives as tankyrase inhibitors |
| WO2014134486A2 (en) | 2013-02-28 | 2014-09-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| US9999680B2 (en) | 2013-02-28 | 2018-06-19 | Immunogen, Inc. | Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents |
| AR095443A1 (en) | 2013-03-15 | 2015-10-14 | Fundación Centro Nac De Investig Oncológicas Carlos Iii | HEREROCICLES CONDENSED WITH ACTION ON ATR |
| WO2014194030A2 (en) | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| US9764039B2 (en) | 2013-07-10 | 2017-09-19 | Sutro Biopharma, Inc. | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| US9840493B2 (en) | 2013-10-11 | 2017-12-12 | Sutro Biopharma, Inc. | Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use |
| GB201510019D0 (en) | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| CA3011455A1 (en) | 2016-01-27 | 2017-08-03 | Sutro Biopharma, Inc. | Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates |
| CN107459519A (en) | 2016-06-06 | 2017-12-12 | 上海艾力斯医药科技有限公司 | Annelated pyrimidines piperidines ring derivatives and its preparation method and application |
| CA3035081A1 (en) | 2016-09-02 | 2018-03-08 | Dana-Farber Cancer Institute, Inc. | Composition and methods of treating b cell disorders |
| MX2019006333A (en) | 2016-12-05 | 2019-09-26 | Apros Therapeutics Inc | Pyrimidine compounds containing acidic groups. |
| US10786502B2 (en) | 2016-12-05 | 2020-09-29 | Apros Therapeutics, Inc. | Substituted pyrimidines containing acidic groups as TLR7 modulators |
| AU2018248293A1 (en) | 2017-04-04 | 2019-10-31 | Lung Cancer Proteomics, Llc | Plasma based protein profiling for early stage lung cancer prognosis |
| US20200207859A1 (en) | 2017-07-26 | 2020-07-02 | Sutro Biopharma, Inc. | Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma |
| EP3684814A1 (en) | 2017-09-18 | 2020-07-29 | Sutro Biopharma, Inc. | Anti-folate receptor alpha antibody conjugates and their uses |
| NL2019801B1 (en) | 2017-10-25 | 2019-05-02 | Univ Leiden | Delivery vectors |
| EP3802519A1 (en) | 2018-06-04 | 2021-04-14 | Apros Therapeutics, Inc. | Pyrimidine compounds containing acidic groups useful to treat diseases connected to the modulation of tlr7 |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
| WO2020060944A1 (en) | 2018-09-17 | 2020-03-26 | Sutro Biopharma, Inc. | Combination therapies with anti-folate receptor antibody conjugates |
| US20220362394A1 (en) | 2019-05-03 | 2022-11-17 | Sutro Biopharma, Inc. | Anti-bcma antibody conjugates |
| KR20220054840A (en) | 2019-08-31 | 2022-05-03 | 이턴 바이오파마 (상하이) 코., 엘티디. | Pyrazole derivatives for FGFR inhibitors and their preparation method |
| EP4114852A1 (en) | 2020-03-03 | 2023-01-11 | Sutro Biopharma, Inc. | Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use |
| US20240058465A1 (en) | 2022-06-30 | 2024-02-22 | Sutro Biopharma, Inc. | Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK276185D0 (en) * | 1984-11-09 | 1985-06-19 | Novo Industri As | MONOCLONAL ANTIBODIES, METHOD OF PREPARING THESE AND THEIR DIAGNOSTIC USES |
| US5019497A (en) * | 1984-11-09 | 1991-05-28 | Lennart Olsson | Human squamous lung carcinoma cell specific antigens and antibodies |
| US5171665A (en) * | 1989-04-17 | 1992-12-15 | Oncogen | Monoclonal antibody to novel antigen associated with human tumors |
| CH685959A5 (en) * | 1992-08-24 | 1995-11-15 | Biomedicals Ag | Diagnostic test kit for the determination of proteins. |
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| US6107103A (en) * | 1996-10-15 | 2000-08-22 | Procyon Bropharma Inc. | Assay for PSP94 protein |
-
1998
- 1998-02-12 DE DE69837529T patent/DE69837529T2/en not_active Expired - Lifetime
- 1998-02-12 ES ES98905576T patent/ES2284200T3/en not_active Expired - Lifetime
- 1998-02-12 WO PCT/IB1998/000361 patent/WO1998035985A1/en active IP Right Grant
- 1998-02-12 AU AU61112/98A patent/AU6111298A/en not_active Abandoned
- 1998-02-12 US US09/022,527 patent/US20020192228A1/en not_active Abandoned
- 1998-02-12 AT AT98905576T patent/ATE359515T1/en active
- 1998-02-12 CA CA2280930A patent/CA2280930C/en not_active Expired - Fee Related
- 1998-02-12 NZ NZ337750A patent/NZ337750A/en not_active IP Right Cessation
- 1998-02-12 JP JP53551498A patent/JP4367866B2/en not_active Expired - Fee Related
- 1998-02-12 DK DK98905576T patent/DK0961780T3/en active
- 1998-02-12 EP EP98905576A patent/EP0961780B1/en not_active Expired - Lifetime
-
2003
- 2003-06-16 US US10/461,424 patent/US20050095249A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998035985B1 (en) | Protein markers for lung cancer and use thereof | |
| DE69837529D1 (en) | PROTEIN MARKERS FOR LUNG CANCER AND ITS USE | |
| TAYLOR et al. | Immunofluorescent localization of vitamin D-dependent calcium-binding protein | |
| ATE198513T1 (en) | PTPALPHA DETERMINATION IN TUMOR DIAGNOSIS AND PROGNOSIS | |
| HUP0004611A2 (en) | April- a novel protein with growth effects | |
| CY1105446T1 (en) | DIAGNOSIS AND TREATMENT OF DISORDERS ASSOCIATED WITH AUR1 AND AUR2 | |
| EA200501772A1 (en) | METHODS OF MEASURING THE EXPRESSION OF GENES FROM FIXED AND PARULIN FABRIC SAMPLE | |
| AU2001253079A1 (en) | Methods, compositions and kits for the detection and monitoring of breast cancer | |
| SE9500023L (en) | Ways to detect cancer | |
| NZ332641A (en) | method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease | |
| Brock | Morphological and biochemical criteria for the separation of Cardium glaucum (Bruguiere) from Cardium edule (L.) | |
| BR9609026A (en) | Process composition for the treatment of cancer and detection for the production of cytokine by tumors to determine the efficacy of an autologous and diagnostic kit for detection for efficacy of autologous cellular compounds | |
| ATE466938T1 (en) | PROSTATE-SPECIFIC GENE PCGEM1 AND METHODS OF USE THEREOF FOR DETECTION, TREATMENT AND PREVENTION OF PROSTATE CANCER | |
| CA2221495A1 (en) | Methods and uses for apoptin | |
| EA200000845A1 (en) | GENE ENCODING NEW CANCER MARKER | |
| CA2366523A1 (en) | Method for analyzing the amount of intraabdominal adipose tissue | |
| Holloway et al. | Localisation and expression of metallothionein immunoreactivity in the developing sheep brain | |
| John et al. | The detection and determination of L-tyrosine O-sulphate in rabbit and other mammalian urine | |
| DE69735676D1 (en) | PROTEIN MARKERS FOR OASOPHAGUS CANCER | |
| ATE304549T1 (en) | HUMAN NETRIN-1 | |
| Tofilon et al. | BCNU-induced sister chromatid exchanges are increased by X irradiation | |
| BR9611255A (en) | nucleic acid, processes for determining a patient's susceptibility to cancer, for diagnosing cancer in a patient, for predicting the relative prospects for the particular appearance of cancer in a patient, for treating cancer and for determining the loss of heterozygosity in a tissue sample , system to detect the presence or absence of, or mutation, in the region of human chromosome 10, polypeptide, molecule and use of nucleic acid and a molecule. | |
| DE69636041D1 (en) | IDENTIFICATION OF BREAST TUMORVIRUS-TYPE SEQUENCES IN BREAST CANCER IN HUMANS | |
| Wang et al. | A luminescence-based test for determining ornithine decarboxylase activity | |
| KR920000943A (en) | Natural-state methods and systems for measuring viability and proliferation of in vitro tissue |